Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 20, Issue 2, pp. 389-397
PubMed
Published By
Print ISSN
Online ISSN
History
- Received July 23, 2020
- Revision received September 10, 2020
- Accepted November 4, 2020
- Published first December 2, 2020.
Article Versions
- Previous version (December 2, 2020 - 07:03).
- Previous version (January 21, 2021 - 09:05).
- You are viewing the most recent version of this article.
Copyright & Usage
©2020 American Association for Cancer Research.
Author Information
- Kim A. Reiss1,2,#,*,
- Max M. Wattenberg1,2,#,
- Nevena Damjanov1,2,
- Elizabeth Prechtel Dunphy1,2,
- Mona Jacobs-Small1,
- M. Judy Lubas1,
- James Robinson1,
- Lisa Dicicco1,2,
- Luis Garcia-Marcano1,2,
- Michael A. Giannone1,2,
- Thomas B. Karasic1,2,
- Emma E. Furth2,3,
- Erica L. Carpenter1,2,
- Andrzej P. Wojcieszynski2,4,
- Robert H. Vonderheide1,2,
- Gregory L. Beatty1,2,##,*, and
- Edgar Ben-Josef2,4,##
- 1Division of Hematology-Oncology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
- 2Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
- 3Department of Pathology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.
- 4Department of Radiation Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.
- ↵*Corresponding Authors:
Kim A. Reiss, University of Pennsylvania, Perelman Center for Advanced Medicine, 3400 Civic Center Boulevard, South Pavilion, Room 10-305, Philadelphia, PA 19104. Phone: 215-360-0735; E-mail: kim.reissbinder{at}pennmedicine.upenn.edu; and Gregory L. Beatty, University of Pennsylvania, Perelman Center for Advanced Medicine, 3400 Civic Center Boulevard, South Pavilion, Room 8-107, Philadelphia, PA 19104. E-mail: gregory.beatty{at}pennmedicine.upenn.edu
February 2021
Volume 20, Issue 2
Volume 20, Issue 2
A Pilot Study of Galunisertib plus Stereotactic Body Radiotherapy in Patients with Advanced Hepatocellular Carcinoma
Jump to section
Advertisement